Levels of clinical condom failure for anal sex: A randomized cross-over trial

被引:8
|
作者
Siegler, Aaron J. [1 ]
Rosenthal, Elizabeth M. [2 ]
Sullivan, Patrick S. [2 ]
Mehta, C. Christina [3 ]
Moore, Renee H. [3 ]
Ahlschlager, Lauren [2 ]
Kelley, Colleen F. [4 ]
Rosenberg, Eli S. [2 ]
Cecil, Michael P. [5 ]
机构
[1] Emory Univ, Dept Behav Sci & Hlth Educ, Rollins Sch Publ Hlth, 1518 Clifton Rd NE, Atlanta, GA 30322 USA
[2] Emory Univ, Dept Epidemiol, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA
[3] Emory Univ, Dept Biostat & Bioinformat, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA
[4] Emory Univ, Sch Med, Atlanta, GA 30322 USA
[5] TheyFit LLC, Covington, LA USA
关键词
HIV PREVENTION; MEN; INTERCOURSE;
D O I
10.1016/j.eclinm.2019.10.012
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Men who have sex with men (MSM) face a 28-fold higher risk of HIV acquisition than men who have sex with women (MSW). Condoms are the most accessible prevention method, with billions produced annually. Due to potentially high clinical failure, international regulatory agencies do not approve condoms for anal sex. This trial sought to provide data regarding approval of condoms for anal sex. Methods: We conducted a blinded, crossover randomized trial among MSM and MSW in Atlanta, Georgia, USA. Crossover conditions were standard condoms, thin condoms, and condoms fitted to each user's penile dimensions. The primary outcome was total clinical failure (slippage and/or breakage), assessed using an intention-to-treat analysis. A mixed methods model assessed differences in odds of failure. The study is registered with ClinicalTrials.gov, NCT02753842, and is completed. Findings: We enrolled 252 MSM and 252 MSW between May 19, 2016 and May 2, 2017. Participants reported a total of 4884 anal or vaginal sex acts using study-provided condoms. For all crossover conditions, clinical failure was lower for anal sex (0.7%, 16/2351) than for vaginal sex (1.9%, 48/2533), (odds ratio 0.40, 95% confidence interval 0.21, 0.75, p < .001)00. There was no difference in odds of failure for anal sex acts between the different types of condoms. Due to study design, nearly all anal sex acts used condom-compatible lubricant (98.3%), yet only a minority of vaginal sex acts (41.6%) used lubricant. Sex acts for which lubricant was used had lower failure for both anal and vaginal sex, with no difference in odds of failure between them. Interpretation: In the largest trial of effectiveness of condoms for anal sex to date, we found remarkably low levels of failure. Condoms should be approved by regulatory agencies for anal sex. Clinicians may recommend condoms as a highly efficacious HIV and STD prevention tool for anal sex. Differences between failure for anal and vaginal sex were likely due to differential use of lubricant. Condom promotion programs should consider providing additional lubricant for all condoms distributed. (C) 2019 Published by Elsevier Ltd.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] The effects of alprazolam on tinnitus: A cross-over randomized clinical trial
    Jalali, Mir Mohammad
    Kousha, Abdorrahim
    Naghavi, Sayed Ebrahim
    Soleimani, Robabeh
    Banan, Rozbeh
    MEDICAL SCIENCE MONITOR, 2009, 15 (11): : PI55 - PI60
  • [2] Effects of Trehalose on Halitosis: A Randomized Cross-Over Clinical Trial
    Miyai, Hisataka
    Tomofuji, Takaaki
    Mizuno, Hirofumi
    Morita, Manabu
    Nakahara, Momoko
    Kataoka, Kota
    Sumita, Ichiro
    Uchida, Yurika
    Toyama, Naoki
    Yokoi, Aya
    Yamanaka-Kohno, Reiko
    Takeuchi, Noriko
    Maruyama, Takayuki
    Ekuni, Daisuke
    HEALTHCARE, 2025, 13 (06)
  • [3] Trimetazidine in heart failure with preserved ejection fraction: a randomized controlled cross-over trial
    van de Bovenkamp, Arno A.
    Geurkink, Kiki T. J.
    Oosterveer, Frank T. P.
    de Man, Frances S.
    Kok, Wouter E. M.
    Bronzwaer, Patrick N. A.
    Allaart, Cor P.
    Nederveen, Aart J.
    van Rossum, Albert C.
    Bakermans, Adrianus J.
    Handoko, M. Louis
    ESC HEART FAILURE, 2023, 10 (05): : 2998 - 3010
  • [4] Aspirin am or pm?: a randomized cross-over trial
    Bonten, T.
    Snoep, J. D.
    Assendelft, W. J.
    van der Meer, V
    Zwaginga, J. J.
    Rosendaal, F. R.
    Eikenboom, H. C. J.
    van der Bom, J. G.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 334 - 335
  • [5] Effectiveness of ginger on pain following periodontal surgery - A randomized cross-over clinical trial
    Menon, Pallavi
    Perayil, Jayachandran
    Fenol, Angel
    Peter, Maya Rajan
    Lakshmi, P.
    Suresh, Reshma
    JOURNAL OF AYURVEDA AND INTEGRATIVE MEDICINE, 2021, 12 (01) : 65 - 69
  • [6] Procalcitonin and the inflammatory response to salt in essential hypertension: a randomized cross-over clinical trial
    Mallamaci, Francesca
    Leonardis, Daniela
    Pizzini, Patrizia
    Cutrupi, Sebastiano
    Tripepi, Giovanni
    Zoccali, Carmine
    JOURNAL OF HYPERTENSION, 2013, 31 (07) : 1424 - 1430
  • [7] Genistein in Sanfilippo Disease: A Randomized Controlled Cross-over Trial
    de Ruijter, Jessica
    Valstar, Marlies
    Kulik, Wim
    Wijburg, Frits
    Wegrzyn, Grzegorz
    MOLECULAR GENETICS AND METABOLISM, 2012, 105 (02) : S26 - S26
  • [8] Randomized cross-over trial of demand oxygen delivery system
    Nagano, Tatsuya
    Kobayashi, Kazuyuki
    Omori, Takashi
    Otoshi, Takehiro
    Umezawa, Kanoko
    Katsurada, Naoko
    Yamamoto, Masatsugu
    Tachihara, Motoko
    Nishimura, Yoshihiro
    MEDICINE, 2020, 99 (19) : E20010
  • [9] Cigarette pack size and consumption: a randomized cross-over trial
    Lee, Ilse
    Blackwell, Anna K. M.
    Hobson, Alice
    Wiggers, Danielle
    Hammond, David
    De-Loyde, Katie
    Pilling, Mark A.
    Hollands, Gareth J.
    Munafo, Marcus R.
    Marteau, Theresa M.
    ADDICTION, 2023, 118 (03) : 489 - 499
  • [10] Deep brain stimulation in treatment resistant schizophrenia: A pilot randomized cross-over clinical trial
    Corripio, Iluminada
    Roldan, Alexandra
    Sarro, Salvador
    McKenna, Peter J.
    Alonso-Solis, Anna
    Rabella, Mireia
    Diaz, Anna
    Puigdemont, Dolors
    Perez-Sola, Victor
    Alvarez, Enric
    Arevalo, Antonio
    Padilla, Pedro P.
    Ruiz-Idiago, Jesus M.
    Rodriguez, Rodrigo
    Molet, Joan
    Pomarol-Clotet, Edith
    Portella, Maria J.
    EBIOMEDICINE, 2020, 51